Skip to main content

Table 3 Acute toxicities after concurrent chemoradiotherapy for bladder preservation

From: Upper Egypt experience in bladder preservation using concurrent chemoradiotherapy

Acute toxicity* I   II   III  
  Group A Group B Group A Group B Group A Group B
  10% 26.7% 16.6% 13.2% 0% 3.3%
  20% 9.9% 6.6% 3.3% 3.3% 3.3%
  3.3% 16.5% 3.3% 6.6% 0% 0%
  40% 40% 6.6% 23.3% 0% 3.3%
  43.3% 46.7% 13.3% 46.7% 0% 6.6%
  60% 23.3% 10% 6.6% 0% 0%
  33.3% 36.7% 60% 53.3% 6.6% 6.6%
  12% 43.3% 20% 36.7% 3.3% 16.5%
  26.6% 6.6% 6.6% 3.3% 0% 3.3%
  0% 0% 0% 0% 0% 0%
  0% 13.2% 0% 0% 0% 0%
  23.3% 76.7% 0% 0% 0% 0%
  1. *(NCI toxicity grading).